Browsing by Title

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:

Showing results 58450 to 58469 of 145227 < previous   next >
Interim review 2005-2009: alliance for health policy and systems research
World Health Organization; Alliance for Health Policy and Systems Research ( 2010 )
Interim review of regionalization of GPA technical cooperation activities in the African region: report by the interim review team
Executive Board, 88 ( 1991 )
Interim specifications for dimethoate : technical and emulsifiable concentrate
World Health Organization. Pesticide Development and Safe Use Unit ( 1986 )
Interim specifications for dimethoate technical and emulsifiable concentrate
World Health Organization. Division of Vector Biology and Control ( 1986 )
Interim specifications for pesticides used in public health
World Health Organization. Division of Control of Tropical Diseases. WHO Pesticide Evaluation Scheme ( 1997 )
Interim specifications for thermal fogging equipment
World Health Organization. Planning, Management and Operations Unit; World Health Organization. Division of Vector Biology and Control ( 1985 )
Interim WHO clinical staging of HVI/AIDS and HIV/AIDS case definitions for surveillance : African Region
World Health Organization. Dept. of HIV/AIDS ( 2005 )
Interlaboratory quality assessment of levels of PCBs, PCDDs and PCDFs in human milk and blood plasma : fourth round of WHO-coordinated study
World Health Organization. Regional Office for Europe; WHO European Centre for Environment and Health (Bilthoven) ( 2000 )

The WHO Regional Office for Europe (EURO) and the WHO European Centre for Environment and Health, Bilthoven Division have coordinated a comprehensive programme on polychlorinated biphenyls (PCBs), polychlorinated dibenzo-p-dioxins (PCDDs) and polychlorinated dibenzofurans (PCDFs) with the aim of assessing the possible adverse health risks of these compounds, and controlling and preventing environmental exposure. To ensure the reliability of the exposure data and to improve comparability of analytical results from different laboratories, EURO has coordinated a number of inter-laboratory quality assessment studies. The fourth round of these studies on levels of PCBs, PCDDs and PCDFs in human milk and blood was conducted between February 1996 and April 1997 with the participation of 24 laboratories. The objectives were to identify laboratories, whose results can be accepted by WHO for exposure assessment studies, and to encourage laboratories to develop and improve their methodologies and to develop an international network for analytical service and expert advice. This report presents the results of this study and a list of accepted laboratories for each of the studied compounds

Interleukin (IL-2) Levels in Past Dengue Infection.
Garcia, Gissel; Sierra, Beatriz; Morier, Luis; Guzman, Miguel; Alvarez, Mayling; Perez, Ana B; Guzman, Maria G ( 2001-12 )
Interleukin 16 (IL-16) / IUS/WHO Standing Committee on Interleukin Designation
IUS/WHO Standing Committee on Interleukin Designation ( 1996 )
Interleukins 12 and 13 levels among beta-thalassaemia major patients
Hashad, R.A.; Hamed, N.A.; El Gharabawy, M.M.; El Metwally, H.A.; Morsi, M.G. ( 2013 )

The role of inflammatory cytokines in the pathophysiology of beta-thalassaemia is still unclear. In this study production levels of interleukins [IL]-12 and IL-13 were measured by commercial ELISA in cultureI supernatants of mitogen-stimulated peripheral blood mononuclear cells from 30 non-splenectomized beta-thalassaemia cases with iron overload and 20 age- and sex-matched healthy individuals. IL-12 levels were significantly lower among cases compared with controls [91.4 pg/mL versus 154.6 pg/mL] while IL-13 levels were significantly higher [42.5 pg/mLversus 5.7 pg/mL]. There was a significant negative correlation between IL-12 and IL-13 levels among beta-thalassaemia cases [r= -0.42]. Patients with beta-thalassaemia alone had higher IL-12 levels than beta-thalassaemia patients who were seropositive for chronic hepatitis B or C virus Infection [140 pg/mL versus 50 pg/mL]; IL-13 levels were slightly lower [65 pg/mL versus 67 pg/mL]. An imbalance In the IL-12/IL-13 axis may be relevant to the pathophysiology of beta-thalassaemia

Intermediate hosts of schistosoma : African Biomphalaria and Bulinus / G. Mandahl-Barth
Mandahl-Barth, George; World Health Organization ( 1958 )
Intermediate level in accelerating the attainment of health for all Africans
Regional Committee for Africa, 38 ( 1988 )
Intermittent malaria treatment as a component of the EPI schedule in Africa
( 2002 )
Intermittent preventive treatment for infants using sulfadoxine-pyrimethamine (SP-IPTi) for malaria control in Africa : implementation field guide
World Health Organization. Dept. of Immunization, Vaccines and Biologicals ( 2011 )
Internal and external costs of malaria surveillance in Thailand : final report of a project supported by the TDR Social and Economic Research Component / Somkid Kaewsonthi ; advisors, Somthas Malikul, Alan G. Harding
Kaewsonthi, Somkid; Malikul, Somthas; Harding, Alan G; UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases ( 1989 )
Internal exposure of the staff involved in the cleanup after the accident at the Chernobyl power plant in 1986 / V. A. Kutkov, I. A. Gusev & S. I. Dementiev
Kutkov, V. A; Gusev, I. A; Dementiev, S. I ( 1996 )
Internal WHO Coordination Meeting for Tsunami-Affected Countries, WHO/SEARO, New Delhi, 28 February 2005.
World Health Organization, Regional Office for South-East Asia ( 2005-02-28 )
International Academy of Legal Medicine and Social Medicine
Executive Board, 73 ( 1983 )
International action
( 1989 )
Showing results 58450 to 58469 of 145227 < previous   next >